Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer

NCT04364672 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of recruitment and funding

Conditions

Breast Cancer

Interventions

DRUG: 18F-labeled DPA-714 PET scan

Sponsor

University of Alabama at Birmingham